CYP2D6 genotype and optimization of breast cancer treatment

被引：0
作者：
Bandres, F. [1 ]
Chicharro, L. M. [2 ]
Tejerina, A. [1 ]
del Saz, M. [2 ]
Fernaacutendez-Santander, A. [2 ]
机构：
[1] Fdn Tejerina, Unidad Docente, Madrid, Spain
[2] Univ Europea Madrid, Madrid, Spain
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(10)70446-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：179 / 179
页数：1
相关论文
共 50 条
[21]   CONCORDANCE OF PHENOTYPE AND GENOTYPE FOR CYP2D6 [J].
MCLEOD, HL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (04) :463-463
[22]   Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment [J].
T. Ramón y Cajal ;
A. Altés ;
L. Paré ;
E. del Rio ;
C. Alonso ;
A. Barnadas ;
M. Baiget .
Breast Cancer Research and Treatment, 2010, 119 :33-38
[23]   Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer [J].
Dezentje, Vincent O. ;
Guchelaar, Henk-Jan ;
Nortier, Johan W. R. ;
van de Velde, Cornelis J. H. ;
Gelderblom, Hans .
CLINICAL CANCER RESEARCH, 2009, 15 (01) :15-21
[24]   Clinical implications of CYP2D6 genotyping on tamoxifen treatment in breast cancer [J].
Dezentje, V. O. ;
Nortier, J. W. R. ;
Guchelaar, H. J. ;
van de Velde, C. J. H. ;
Gelderblom, H. .
EJC SUPPLEMENTS, 2008, 6 (07) :56-56
[25]   Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment [J].
Ramon y Cajal, T. ;
Altes, A. ;
Pare, L. ;
del Rio, E. ;
Alonso, C. ;
Barnadas, A. ;
Baiget, M. .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) :33-38
[26]   Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors [J].
Gressier, F. ;
Verstuyft, C. ;
Hardy, P. ;
Becquemont, L. ;
Corruble, E. .
JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (01) :35-42
[27]   Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors [J].
F. Gressier ;
C. Verstuyft ;
P. Hardy ;
L. Becquemont ;
E. Corruble .
Journal of Neural Transmission, 2015, 122 :35-42
[28]   The effect of CYP 2D6 genotype and CYP2D6 inhibitors on tamoxifen [J].
Stearns, V ;
Hayes, DF ;
Jin, Y ;
Ullmer, L ;
Nguyen, A ;
Storniolo, AM ;
Flockhart, U ;
Desta, Z .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :5S-5S
[29]   CYP2D6 Genotyping and the Use of Tamoxifen in Breast Cancer [J].
Berry, Donald .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (17) :1267-1269
[30]   CYP2D6 genotypes in Spanish women with breast cancer [J].
Ladona, MG ;
Abildua, RE ;
Ladero, JM ;
Roman, JM ;
Plaza, MA ;
Agundez, JAG ;
Munoz, JJ ;
Benitez, J .
CANCER LETTERS, 1996, 99 (01) :23-28
12345